Related Experiment Video
Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
How can we monitor glycaemic variability in the clinical setting?
S Inchiostro1, R Candido, F Cavalot
1Internal Medicine II and Diabetes Centre, S. Chiara Hospital, Trento, Italy.
Abstract:
No universal consensus exists on how to express glycaemic variability. Among other parameters, standard deviation of blood glucose values, mean amplitude of glycaemic excursions (MAGE), the Low Blood Glucose Index (LBGI) and the High Blood Glucose Index (HBGI), which were subsequently combined into the Average Daily Risk Range (ADRR), mean of daily differences (MODD) and glycaemic variability index (GVI) are highlighted. The continuous glucose monitoring in research and clinical settings has been a great help for a comprehensive approach to circadian blood glucose evaluation and identification of individual patterns, mainly in type 1 diabetes, but recently also in type 2 diabetes. In everyday clinical practice the judicious use of self-monitoring of blood glucose in an educational setting involving the patient and the care team is an unreplaceable tool to effectively and safely guide behavioural and drug therapy.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia
Hypoglycemia and Glucagon
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

